on Thyssenkrupp Nucera AG & Co. KGaA (isin : DE000NCA0001)
Thyssenkrupp Nucera Reports FY 2025/26 Preliminary Figures
Thyssenkrupp Nucera AG & Co. KGaA announced its preliminary financial figures for the fiscal year 2025/26. The company saw an increase in order intake across both segments, achieving positive free cash flow. However, EBIT fell below guidance due to additional project costs in the green hydrogen (gH2) segment.
For FY 2025/26, Group sales are projected at approximately €450 million, with EBIT expected at €–136 million. These figures are below previous guidance, impacted by nearly €40 million in expenses related to supplier defects rectification in the gH2 segment. The gH2 segment reported sales of €84 million, with an EBIT of €–197 million.
In contrast, the Chlor-Alkali (CA) segment achieved its sales and EBIT targets, with sales reaching about €365 million and EBIT increasing to €61 million, marking a 17% EBIT margin.
Order intake is anticipated to grow by 60%, reaching €559 million, supporting future sales growth. Despite financial challenges, free cash flow remained positive at €16 million.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Thyssenkrupp Nucera AG & Co. KGaA news